AstraZeneca said Tuesday it’s planning to invest $50 billion in expanding its manufacturing and research presence in the U.S. by 2030, as worries about tariffs loom over the industry.
AstraZeneca Plans to Invest $50B in US Manufacturing and Research by 2030
view original post